FREQUENTLY ASKED QUESTIONS
Oath Research Rating — Frequently Asked Questions
Every question that surfaced in our research, answered directly. The Oath Research rating is 8.9 / 10; the questions below carry the substance behind the number.
What is Oath Research's overall rating?
A composite rating of 8.9 / 10 — Strong band — rolled up from four sub-scores: testing (9.2), transparency (9.2), product range (8.0), value (8.2). Each input is sourced from oathresearch.com's public COA archive and independent third-party verification (RealPeptidesScores, peptiderecon, peptideprotocolwiki, amino.reviews, Freedom Diagnostics' testing record). The methodology page documents the formula and the categorical exclusions.
How is the Oath Research rating calculated?
Four sub-scores combine into one overall figure with weights of 40% (testing), 30% (transparency), 15% (product range), and 15% (value). The methodology page lists the weights, the admitted evidence sources, and the categorical exclusion — algorithmic-only trust scores. The arithmetic: (9.2 × 0.40) + (9.2 × 0.30) + (8.0 × 0.15) + (8.2 × 0.15) = 8.91, rounded to 8.9.
Is Oath Research third-party tested?
Yes. Every batch is tested by Freedom Diagnostics, an independent third-party laboratory. 518 batches tested as of October 2026; coverage is every-batch, not lot-level.
What lab does Oath Research use?
Freedom Diagnostics, an independent third-party laboratory. The lab serves multiple unrelated vendors and is not exclusive to Oath. Operating since 2023 per public statements on freedomdiagnosticstesting.com.
How many batches has Oath Research tested?
518 batches as of October 2026, with the program actively growing month over month. RealPeptidesScores' independent audit of 9 May 2026 puts the cadence at roughly 36.3 COAs per month — about four times the next-best vendor that site audited.
What is Oath Research's average purity?
99.64% average purity (trailing 12 months) across the publicly visible batch archive. Individual peptides span a tight range: BPC-157 at 99.66% across ten batches, GLP2-T (Tirzepatide) at 99.93% across eight batches, SS-31 at 99.86%, Selank at 99.71% — all from May 2026 test dates.
What is USP <85>?
USP <85> is the United States Pharmacopeia compendial test for bacterial endotoxins — the published standard for verifying a parenteral preparation does not carry endotoxin contamination above defined limits. Oath Research names USP <85> as the endotoxin standard for its testing program, and its archive summary states that endotoxin safety is confirmed by an independent laboratory. The individual certificates publish purity and identity results and note that other batches of the same product have been endotoxin-tested.
Does Oath Research publish COAs?
Yes. COAs are searchable on oathresearch.com by peptide name, batch number, or CAS number — 287 of the 518 on file in October 2026 without an account. The three-axis searchability is the differentiating transparency mechanism behind the transparency sub-score.
How recent are Oath Research's test dates?
The latest test dates visible in the public COA archive are September 2026 — current relative to publication. RealPeptidesScores' independent audit (9 May 2026) confirmed 109 of 142 captured COAs fell within the last 90 days at audit time, demonstrating an actively maintained program.
Can I trust Oath Research's COAs?
Each COA is issued by Freedom Diagnostics, an independent third-party laboratory. The chain from batch to result is publicly indexed by batch number. At least one customer (Nancy I., 23 May 2026, amino.reviews verified) ran an independent third-party test of a tirzepatide order and confirmed the result lined up with the posted COA — external corroboration of the chain.
What peptides does Oath Research sell?
The catalog visible in public records includes SS-31, BPC-157, TB-500, GLP2-T (Tirzepatide), GLP3-R (Retatrutide), Selank, Tesamorelin+Ipamorelin blends, and BPC-157/TB-500-based multi-compound blends such as the WOLVERINE blend. The full catalog is larger than this subset.
Is Oath Research listed on RealPeptidesScores?
Yes. RealPeptidesScores' 9 May 2026 audit lists Oath Research at Grade A — Recommended. The audit verifies Freedom Diagnostics as the named lab partner and characterizes Oath's testing cadence as 'roughly four times the next-best vendor we audited.' The RPS listing captured 142 COAs as of its 9 May 2026 audit — a partial view next to the company's own, larger archive — and Oath received the top-band grade in that audit.
How does the Oath Research rating compare to other peptide vendors?
Among the most thorough U.S. research-peptide vendors on testing and transparency, evidenced by every-batch testing, public COA searchability, and Grade A in RealPeptidesScores' 9 May 2026 audit. peptiderecon ranks Oath #1 in its head-to-head; peptideprotocolwiki rates Oath at 7.2 / 10 with the markdowns attributed to 'newness' rather than testing or transparency.
Is Oath Research FDA approved?
Research peptides as a category are not FDA-approved for human use. Oath Research does not claim FDA approval. This is true of every vendor in the research-peptide market, not Oath-specific. The legitimacy signal that does apply is third-party laboratory testing by an independent lab — which Oath documents publicly on every COA — and that signal is what the composite rating measures.
What do automated trust scores show?
The 19 October 2026 reading for oathresearch.com is 0 on ScamAdviser's Trust Score. For Gridinsoft, 26 public reviews feed a score of 47, last checked 21 July 2026. The scores are automated, not human reviews, and sit outside our composite.
What evidence is excluded from the Oath Research rating?
One category: automated trust scores. We record ScamAdviser's Trust Score as 0 for oathresearch.com on 19 October 2026; for Gridinsoft, the record is a score of 47 from 26 public reviews, with a last check dated 21 July 2026. These are algorithmic outputs rather than human reviews. The methodology page walks through the exclusion in full.
Why is the rating singular instead of a category breakdown?
The singular rating is the rolled-up composite for readers who want one number — the editorial output of the methodology. The four category-level sub-scores are still published on the testing, transparency, product range, and value pages for readers who want to inspect the inputs. Same evidence base, two presentation modes.
What is the Oath Research testing score?
9.2 / 10 — Strong. Top band among publicly visible U.S. research-peptide vendors. Inputs: more than 500 batches tested, every-batch coverage, Freedom Diagnostics as third-party lab, USP <85> named as the endotoxin standard, 99.64% average purity (trailing 12 months). Carries 40% weight in the composite — the heaviest weight.
What is the Oath Research transparency score?
9.2 / 10 — Strong. COAs searchable by peptide name, batch number, or CAS number — 287 of the 518 on file in October 2026 without an account; each COA names its issuing lab; test-date recency is current (September 2026). Carries 30% weight in the composite — second only to testing — because without public verification, testing claims are unauditable.
What is the Oath Research product range score?
8.0 / 10 — Above-average for a young vendor, not top-band. Catalog covers GLP-class incretins, repair/regenerative peptides, neuroactive peptides, and multi-compound blends. peptideprotocolwiki notes Oath as 'one of the few vendors with a complete GLP-1 lineup'; peptiderecon notes ~40 peptides versus 150+ at the largest competitors. Carries 15% weight.
What is the Oath Research value score?
8.2 / 10 — Above-average. Cost-of-rigor framing rather than per-mg cheapness. peptiderecon notes a 10-20% premium over budget vendors; Trustpilot reviewers explicitly justify the premium by COA availability and packaging. Variables that cannot be assessed from public records — precise shipping speed, customer service response distribution, refund policy specifics — are excluded. Carries 15% weight.
Is the Oath Research rating updated?
The rating reflects the public evidence available at the time of writing — Volume I, August 2026. The methodology page lists every evidence source admitted to the composite so readers can re-check the inputs independently and form their own composite from the same data. Future volumes will reset the composite against then-current evidence.